You may have heard of CAR T-cell therapy, but now there's an effort by Siddhartha Mitra, PhD, and his team to develop CAR M. The goal? To re-engineer marcophages instead of T cells, to "eat" cancer cells: https://bit.ly/3RjG52h

Former NBA player Jason Collins passed away this week after a battle with Stage 4 glioblastoma, a rare form of brain cancer. In this Q&A, CU Anschutz Cancer Center member Douglas Ney, MD, talks about glioblastoma and its rising prevalence in younger patients ⬇️ https://bit.ly/497RCIy

CU Anschutz Cancer Center's Tejas Patil, MD, and Peter Fecci, MD, PhD, are joining forces to investigate a new way to treat leptomeningeal disease stemming from a form of lung cancer: https://news.cuanschutz.edu/cancer-center/patil-fecci-leptomeningeal-disease

Leading with intention and self-awareness, Diana Cittelly, PhD, creates a collaborative space that values transparency, growth, and diverse working styles. See the full interview here: youtu.be/ttGsG6o7oX0?...

Congrats to CU Anschutz Cancer Center's Curtis Henry, PhD, on being named the American Association of Immunologists (@aai.org) Vanguard Award winner in recognition of his research achievement and exemplary career success: https://news.aai.org/2026/05/06/curtis-j-henry-receives-aai-vanguard-award/

Some cancer drugs disrupt taste by changing the cells inside taste buds, CU Anschutz Cancer Center-led research shows: https://bit.ly/4d1gcNr

Brain Cancer Awareness Month: CU Anschutz Cancer Center's Peter Fecci, MD, PhD, shares the origins of cancer in the brain and how different types are treated: https://bit.ly/4tTxhyF

How does chemotherapy work, and what are some of its side effects? CU Anschutz Cancer Center member Jenny Xiang, MD, answers these questions: https://bit.ly/4ut69Gz

Cancer center members Joanna Arch, PhD, and Jean Kutner, MD, MSPH, created an intervention for advanced cancer patients to help them with anxiety, depression, and advance care planning: https://bit.ly/41OVKZI

The best way to treat pancreatic cancer? Stop it from developing in the first place. That’s the thrust of a presentation delivered by CU Anschutz Cancer Center leader Hatim Sabaawy, MD, PhD, at the Rocky Mountain Pancreatic Cancer Symposium: https://bit.ly/4ueYc7U

Daraxonrasib is trending — here’s what to know 👀 “This could be a game changer for pancreatic cancer,” says Christopher Lieu, MD. (@cucancercenter.bsky.social) As the FDA fast-tracks its review, early data is giving new hope in a disease with limited options. Read more: https://bit.ly/4rU8wRn

#SkinCancerAwarenessMonth: Interim Director @jdegregori.bsky.social#SkinCancerAwarenessMonth shares his experience of having two instances of squamous cell carcinoma and how you can prevent skin cancer. Learn more about skin cancer: https://bit.ly/467Yv97

The Second Annual International Rocky Mountain Pancreatic Cancer Symposium created a space for showcasing the latest research and an opportunity to further collaboration in the fight against pancreatic cancer, both here in Colorado and across the globe! @cudeptsurg.bsky.social

CU Anschutz Cancer Center member Shi-Long Lu, MD, PhD, and his team found a breakthrough in saliva-based cancer detection. Then the COVID-19 pandemic began, pivoting their work to build one of Colorado’s largest COVID-19 saliva-testing labs. https://youtu.be/zNTZ5NbJM8g?si=wyNYEO0EbozKZJXR

Testicular Cancer Awareness Month: CU Anschutz Cancer Center's Elizabeth Kessler, MD, shared with us how testicular cancer survivors will often have emotional side effects, including anxiety and depression ⬇️ https://news.cuanschutz.edu/cancer-center/survivorship-testicular-cancer

Colorado Springs resident Dan Rathke stresses cancer screening after his experience of a screening test finding indications of Barrett’s esophagus, a precancerous condition that can be a warning sign of an often-aggressive subtype of esophageal cancer ⬇️ https://bit.ly/4vLT0K4

The second annual Rady Center 5K Fun Run on Saturday morning brought the community together at @cuanschutz.bsky.social to raise awareness for esophageal cancer! 💜

Congrats to CU Anschutz Cancer Center's Thomas Flaig, MD, on receiving the Excellence in Engagement Award from the National Comprehensive Cancer Network! See the full awards announcement: https://bit.ly/3QmdB7M

In this Q&A, we turned to Linda Overholser, MD, MPH, to better understand the unique challenges facing survivors of pediatric cancer ⬇️ https://news.cuanschutz.edu/cancer-center/overholser-pediatric-cancer-survivorship

CU Anschutz Cancer Center member Kyle Concannon, MD, and his team, presented their latest research on targeting tyrosine kinase inhibitor-resistant lung cancer cells at this year's annual meeting of the American Association for Cancer Research ⬇️ https://bit.ly/4cE2Epp

Are young people safe from these cancers? Are they always caused by smoking? What about mouthwash and cell phones? Carissa Thomas, MD, PhD, FACS, sets the record straight ⬇️ https://news.cuanschutz.edu/cancer-center/thomas-head-neck-cancer-myths

Christopher Lieu, MD, was a panel moderator at this year's NCCN 2026 Annual Conference, where he spoke about the importance of multidisciplinary care when it came to responding to the rise in cancer incidence in people under 50: https://bit.ly/3QkDlkQ

CU Anschutz Cancer Center research presented at #ASPO2026 says fear-based images, graphic depictions of diseased lungs, ominous warnings, and blame-focused language may discourage participation in lung cancer screening ⬇️ https://news.cuanschutz.edu/cancer-center/reframing-lung-cancer-screening

In her leadership, Lia Gore, MD, creates space for diverse perspectives, recognizing that the best solutions come from shared ideas. Full interview: youtu.be/PtQ7DPwgwG0?...

When winter and spring collide! ❄️ 🌸

In this Q&A, CU Anschutz Cancer Center's Sachin Wani, MD, breaks down the symptoms of "silent reflux" and when it may be time to seek out specialized care: https://news.cuanschutz.edu/medicine/silent-reflux-cancer-risk

Breast cancer hijacks the lung repair system to fuel tumor growth, CU Anschutz Cancer Center researchers find: https://bit.ly/3NGY01H

Tin Tin Su, PhD, believes in following the data wherever it leads. Instead of fearing unexpected results, she embraces them as opportunities to learn, adapt, and discover something new. Watch the full interview: youtu.be/U1KjNDA7eRs?...

Learn about the latest advancements in pancreatic cancer research, diagnosis, and surgical innovation! RSVP for the Second Annual International Rocky Mountain Pancreatic Cancer Symposium on April 30: https://bit.ly/3Od7EsT

#EsophagealCancerAwarenessMonth: Researchers have developed a new AI tool with a 90% accuracy rate to predict Barrett’s Esophagus recurrence after therapy: https://bit.ly/4c8wzG4

Help fund cancer research, clinical trials, and services here in Colorado. And you could win a 2026 Jeep Grand Cherokee L Limited 4x4! Learn more about this Cancer League of Colorado raffle here: https://cancerleagueraffle-org.3dcartstores.com/

Yesterday's joint scientific retreat between the Developmental Therapeutics and Molecular and Cellular Oncology Programs highlighted how these two programs collaborate to advance basic science to translational discovery and implementation. 🔬

Overseen by CU Anschutz Cancer Center leader Enrique Soto Perez de Celis, MD, PhD, the CU Anschutz Geriatric Oncology Clinic helps older patients who need specialized care ⬇️ https://news.cuanschutz.edu/cancer-center/geriatric-oncology-clinic

At the seventh annual Paul R. O’Hara II Esophagogastric Symposium, over 70 participants learned about the innovations in esophageal cancer screening, research, and treatment. 💜

PhD student at @cuanschutz.bsky.social, Samuel Burciaga, and his team are refining CAR-T cell therapies through the exploration of how immune cells can be engineered to be more effective at targeting cancer ⬇️ https://bit.ly/4sH76L1

Research from CU Anschutz Cancer Center's Heather Leach, PhD, and Rebecca Scalzo, PhD, shows that breast cancer survivors who are receiving selective estrogen receptor modulators may reduce their risk of diabetes by taking more breaks from sitting: https://bit.ly/4sGeupR

Head and Neck Cancer Awareness Month: Jessica McDermott, MD, raises awareness of HPV, which has become an increasingly prevalent risk factor for head and neck cancers: https://bit.ly/3TRmmG7

Becky Grubb credits the CU Anschutz Cancer Center’s multidisciplinary care and clinical trials – plus a ‘huge village’ of support – for her quality of life after a stage IV colorectal cancer diagnosis: https://bit.ly/3PHzjTp

Thomas Flaig (@tomflaigmd.bsky.social), MD, Vice Chancellor for Research at CU Anschutz, continues to lead global bladder cancer treatment guidelines through his role at NCCN. At the NCCN Annual Conference, he outlined new therapies, research, and practical insights to improve patient care. (1/6)

#NationalDoctorsDay: To prevent and conquer cancer together, it wouldn't be possible without our doctors. Thank you for all that you do! 💛 🖤

Cathy Bradley, PhD, CU Anschutz Cancer Center deputy director and dean of the Colorado School of Public Health, shares the importance of the Colorado Cancer Screening Program. Learn more: https://bit.ly/4aSeQC2

"As soon as they told me about this trial, I said, ‘I’m all in,’” said Teresa Anne Volgenau about a clinical trial overseen by Stacy Fischer, MD, which is evaluating the effectiveness of the psychedelic drug psilocybin and talk therapy ⬇️ https://bit.ly/4bIBMEj

As part of an international study, Nikita Pozdeyev, MD, and Christopher Gignoux, PhD, uncovered previously-unknown genetic variants linked to thyroid cancer, along with clues to predict the cancer’s aggressiveness ⬇️ https://bit.ly/4t6uvFh

Colorectal Cancer Awarness Month: Swati Patel, MD, points to exciting developments, including vaccines and clinical trials, to help people with Lynch syndrome avoid cancer ⬇️ https://news.cuanschutz.edu/cancer-center/lynch-syndrome-colorectal-cancer-risk

Last chance to register for the Seventh Annual Paul R. O'Hara II Esophagogastric Cancer Symposium. Gain comprehensive knowledge of esophagogastric conditions, including screening guidelines, treatment strategies, and more! Register here: https://bit.ly/4t25ond

Enrique Soto Pérez de Celis, MD, PhD, a geriatric oncology specialist, recently took up the challenge of finding a better path forward for this older group of patients facing both cancer and loneliness ⬇️ https://news.cuanschutz.edu/news-stories/treating-loneliness-in-older-patients-with-cancer

When it comes to cancer care, what exactly are targeted cancer therapies? CU Anschutz Cancer Center member Urs Weber, MD, walks us through these powerful weapons in the cancer-fighting arsenal: https://news.cuanschutz.edu/cancer-center/targeted-cancer-therapies-explained

Join us for a University of Colorado Anschutz Cancer Center joint scientific retreat hosted by the Developmental Therapeutics (DT) and Molecular and Cellular Oncology (MCO)! Learn more and register by March 31 here: https://bit.ly/4sUMUoI

After chemotherapy stopped working for Colin Kiesel, cancer center leader Christopher Lieu, MD, pivoted his treatment to Zenocutuzumab, a newly FDA-approved targeted therapy ⬇️ https://bit.ly/4bFmOQG

Laura Graham, MD, a medical oncologist here at the CU Anschutz Cancer Center, is leading a national clinical trial focused on a more personalized path for prostate cancer care: https://bit.ly/46UtqYL